Diamedica Therapeutics Inc (DMAC)
R&D Expenses
$29.28M
TTM · Period ending: · USD
DMAC R&D Expenses
Latest reported$29.28Mperiod ending
Latest reported$29.28Mperiod ending
DMAC TTM R&D Expenses ($0.00 → $29.28M)
TTM R&D Expenses
High-resolution chart · PNG
DMAC r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 29,276,000 | |
| 26,945,000 | |
| 24,614,000 | |
| 24,385,000 | |
| 22,931,000 | |
| 21,037,000 | |
| 19,057,000 | |
| 16,264,000 | |
| 14,553,000 | |
| 13,168,000 | |
| 13,110,000 | |
| 11,703,000 | |
| 10,071,000 | |
| 9,483,000 | |
| 7,839,000 | |
| 7,440,000 | |
| 8,132,000 | |
| 8,333,000 | |
| 8,765,000 | |
| 10,014,000 | |
| 9,840,000 | |
| 9,284,000 | |
| 8,227,000 | |
| 6,909,000 | |
| 6,368,000 | |
| 6,642,000 | |
| 7,900,000 | |
| 8,505,937 | |
| 8,098,937 | |
| 7,294,937 | |
| 5,478,937 | |
| 3,717,234 | |
| 2,997,336 | |
| 2,840,010 | |
| 3,206,000 | |
| 2,983,355 | |
| 3,234,042 | |
| 2,689,724 | |
| 1,772,333 | |
| 1,612,531 | |
| 1,018,226 | |
| 852,981 | |
| 701,481 | |
| 858,679 | |
| 1,442,167 | |
| 2,183,612 | |
| 3,354,713 | |
| 1,232,151 | |
| 1,669,353 | |
| 2,617,056 | |
| 2,828,017 | |
| 3,677,681 | |
| 4,799,474 | |
| 4,920,195 | |
| 4,187,204 | |
| 3,419,707 | |
| 2,496,701 | |
| 1,811,170 | |
| 2,505,889 | |
| 4,419,756 | |
| 3,219,091 | |
| 2,030,165 | |
| 803,050 | |
| 826,994 | |
| 1,049,456 | |
| 1,080,377 | |
| 1,278,004 | |
| 735,338 | |
| 906,363 | |
| 1,196,501 | |
| 1,065,144 | |
| 1,178,109 | |
| 865,543 | |
| 818,886 | |
| 651,017 | |
| 909,627 | |
| 820,058 | |
| 407,133 | |
| 303,958 | |
| 156,648 | |
| 0 | |
| 0 | |
| 0 |